• Research Faculty

  • A photo of Stella Davies.

    Stella M. Davies, MBBS, PhD, MRCP Director, Bone Marrow Transplantation and Immune Deficiency


    A photo of Michael Grimley.

    Michael S. Grimley, MD Member, Langerhans Cell Histiocytosis Center

    has clinical research interests in the treatment of graft versus host disease (GVHD) after transplant and the use of umbilical cord blood as a stem cell source.


    A photo of Michael Jordan.

    Michael B. Jordan, MD Faculty, Langerhans Cell Histiocytosis Center

    specializes in caring for children with histiocytic disorders, primary immune deficiencies, or who are undergoing bone marrow transplantation. His laboratory focuses on understanding effector T cell function, immune regulation, and the pathogenesis of hemophagocytic lymphohistiocytosis. He is also conducting preclinical scientific studies in addition to a translational clinical trial.


    A photo of Ashish Kumar.

    Ashish R. Kumar, MD, PhD Director, Langerhans Cell Histiocytosis Center

    is a pediatric hematologist/oncologist whose lab is investigating the biology childhood cancers and blood diseases. The current focus of research in the lab is on infant leukemia and LCH.
    Visit the Kumar Lab.


    A photo of Rebecca Marsh.

    Rebecca A. Marsh, MD Clinical Director, Primary Immune Deficiency Program

    is an immunologist and bone marrow transplant physician. Her research focuses on understanding the pathogenesis of HLH in patients with XIAP deficiency, developing new diagnostic laboratory assays, and improving the outcomes of allogeneic bone marrow transplantation in patients with primary immune deficiencies. 


    A photo of Kasiani Myers.

    Kasiani C. Myers, MD

    is a bone marrow transplant physician focused on translational research in bone marrow failure and Fanconi anemia (FA), specifically the longitudinal evaluation of hematopoiesis in FA as a model for de novo leukemogenesis. These studies will lead to development and clinical trials of targeted therapies to preserve stem cell function through the elucidation of the steps in the pathway towards marrow failure and malignant transformation.


    A photo of Kimberly Risma.

    Kimberly A. Risma, MD, PhD Director, Allergy and Immunology Fellowship Program

    is focused on the molecular and cellular bases of primary disorders of immune deficiency and dysregulation, especially as it relates to lymphocyte cytotoxicity. She studies the pathologic consequences of missense mutations in perforin identified in patients with hemophagocytic lymphohistiocytosis (HLH) and strives to develop novel therapies through gene therapy or small molecule chaperones.
    Visit the Risma Lab website.